SCHEMBL8013036

SCHEMBL8013036

C=C(C)C(=O)OCC[N+](C)(C)CC(=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.46
TSHR P16473 4/20 0.44
CHRM5 P08912 5/20 0.41
CHRM1 P11229 5/20 0.41
CHRM3 P20309 5/20 0.41
CHRM2 P08172 4/20 0.38
CHRM4 P08173 4/20 0.38
CHRNB2 P17787 3/20 0.38
CHRNA7 P36544 3/20 0.38
CHRNA4 P43681 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HTR1A P08908 2/20 0.38
PGR P06401 1/20 0.38
TBXA2R P21731 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA10 Q9GZZ6 1/20 0.38
CHRNA9 Q9UGM1 1/20 0.38
GALR3 O60755 2/20 0.38
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23628727 0.90 THRB (0.53) THRBTSHRCHRM5CHRM1CHRM3
SCHEMBL19484355 0.88 TSHR (0.53) THRBTSHRCHRM5CHRM1CHRM3
SCHEMBL11100109 0.87 THRB (0.47) THRBTSHRCHRM5CHRM1CHRM3
Acetic Acid SCHEMBL8642371 0.87 THRB (0.43) THRBTSHRCHRM5CHRM1CHRM3
SCHEMBL10300016 0.87 THRB (0.53) THRBTSHRCHRM5CHRM1CHRM3
SCHEMBL536434 0.86 THRB (0.43) THRBTSHRCHRM5CHRM1CHRM3
SCHEMBL2277551 0.86 THRB (0.46) THRBTSHRCHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL1904155 0.86 THRB (0.46) THRBTSHRCHRM5CHRM1CHRM3
Bromide SCHEMBL725843 0.85 THRB (0.52) THRBTSHRCHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL32674543 0.84 THRB (0.44) THRBTSHRCHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025065051-A1 PLASMA-MEDIATED POLYMER GRAFTING METHODOLOGY THE UNIVERSITY OF SYDNEY (AU) 2025-04-03 WO claimed
US-12545747-B2 Method, kit, and device for preparing glycan from glycoprotein NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2026-02-10 US disclosed
US-20250387315-A1 Dental Varnishes Based On Cationic Polymer Dispersions IVOCLAR VIVADENT AG (LI) 2025-12-25 US disclosed
US-20250347195-A1 OPTIMIZING CO2 GEOSEQUESTRATION WITH RESPONSIVE TRACERS ARAMCO SERVICES COMPANY (US) 2025-11-13 US disclosed
US-20250206957-A1 ANTI-FOGGING COMPOSITION, TRANSLUCENT MEMBER AND METHOD FOR PRODUCING THE SAME, AND OPTICAL UNIT AND METHOD FOR PRODUCING THE SAME STANLEY ELECTRIC CO., LTD. (JP) 2025-06-26 US disclosed
WO-2025070814-A1 SUGAR CHAIN PREPARATION METHOD AND SUGAR CHAIN ANALYSIS METHOD 住友ベークライト株式会社 2025-04-03 WO disclosed
WO-2025065051-A1 PLASMA-MEDIATED POLYMER GRAFTING METHODOLOGY THE UNIVERSITY OF SYDNEY (AU) 2025-04-03 WO disclosed
WO-2024241938-A1 CELL CHIP 住友化学株式会社 2024-11-28 WO disclosed
WO-2024203883-A1 OPHTHALMIC MEDICAL INSTRUMENT AND MANUFACTURING METHOD THEREFOR 三菱ケミカル株式会社 2024-10-03 WO disclosed
EP-3495400-B1 BLOCK COPOLYMER AND SURFACE TREATMENT AGENT USING SAME TOSOH CORP (JP) 2024-08-28 EP disclosed
US-20180142119-A1 CURABLE COMPOSITION, COATING, AND LAMINATE FUJIFILM CORPORATION (JP) 2018-05-24 US disclosed
US-9958445-B2 Solid-phase support, ligand-binding solid-phase support, method for detecting or separating target substance, and method for producing the solid-phase support JSR CORPORATION (JP) 2018-05-01 US disclosed
US-9956324-B2 Medical material, and medical device using the medical material TERUMO KABUSHIKI KAISHA (JP) 2018-05-01 US disclosed
US-9914788-B2 Active energy ray-curable composition and antistatic film FUJIFILM CORPORATION (JP) 2018-03-13 US disclosed
US-9797886-B2 Agglutination enhancer WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2017-10-24 US disclosed
EP-3193172-A1 SOLID PHASE CARRIER, LIGAND-BOUND SOLID PHASE CARRIER, METHOD FOR DETECTING OR SEPARATING TARGET SUBSTANCE, AND METHOD FOR PRODUCING SOLID PHASE CARRIER JSR Corporation (JP) 2017-07-19 EP disclosed
US-20160069871-A1 MAGNETIC BEAD, LIGAND-BINDING BEAD, METHOD FOR DETECTING OR SEPARATING TARGET SUBSTANCE, AND METHOD FOR PRODUCING THE MAGNETIC BEAD JSR CORPORATION (JP) 2016-03-10 US disclosed
EP-0779318-B1 Silicon-containing block copolymer WAKO PURE CHEMICAL INDUSTIES L (JP) 2000-02-16 EP disclosed
US-5760136-A FORMING AN ADDITION-CONDENSATION COPOLYMER BY POLYMERIZING AN AZO-CONTAINING POLYSILOXANE AND AN UNSATURATED MONOMER; CATIONIC AND NONIONIC POLYMERS; POLYAMPHOLYTES; COATINGS; ADHESIVES; PAINTS; HAIR COSMETICS WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1998-06-02 US disclosed
EP-0779318-A1 Silicon-containing block copolymer Wako Pure Chemical Industries, Ltd. (JP) 1997-06-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160069871-A1 MAGNETIC BEAD, LIGAND-BINDING BEAD, METHOD FOR DETECTING OR SEPARATING TARGET SUBSTANCE, AND METHOD FOR PRODUCING THE MAGNETIC BEAD CD14, NMBR, NMUR2 THRB 2059/4885TSHR 1547/4885CHRM5 472/4885
US-20250387315-A1 Dental Varnishes Based On Cationic Polymer Dispersions TUBA3C, DNMT1, TUBA1A THRB 1217/4885TSHR 1494/4885CHRM5 1532/4885
US-12545747-B2 Method, kit, and device for preparing glycan from glycoprotein FUT7, FUT4, SIGLEC7 THRB 388/4885TSHR 565/4885CHRM5 553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.